Zeng Wei-Juan, Hu Wen-Qin, Wang Lin-Wei, Yan Shu-Guang, Li Jian-Ding, Zhao Hao-Liang, Peng Chun-Wei, Yang Gui-Fang, Li Yan
Departments of Oncology & Pathology, Zhongnan Hospital of Wuhan University, Hubei Key Laboratory of Tumor Biological Behaviors & Hubei Cancer Clinical Study Center, Wuhan 430071, China.
BMC Surg. 2014 May 16;14:29. doi: 10.1186/1471-2482-14-29.
Gastric cancer (GC) is the third leading cause of cancer death in China and the outcome of GC patients is poor. The aim of the research is to study the prognostic factors of gastric cancer patients who had curative intent or palliative resection, completed clinical database and follow-up.
This retrospective study analyzed 533 GC patients from three tertiary referral teaching hospitals from January 2004 to December 2010 who had curative intent or palliative resection, complete clinical database and follow-up information. The GC-specific overall survival (OS) status was determined by the Kaplan-Meier method, and univariate analysis was conducted to identify possible factors for survival. Multivariate analysis using the Cox proportional hazard model and a forward regression procedure was conducted to define independent prognostic factors.
By the last follow-up, the median follow-up time of 533 GC patients was 38.6 mo (range 6.9-100.9 mo), and the median GC-specific OS was 25.3 mo (95% CI: 23.1-27.4 mo). The estimated 1-, 2-, 3- and 5-year GC-specific OS rates were 78.4%, 61.4%, 53.3% and 48.4%, respectively. Univariate analysis identified the following prognostic factors: hospital, age, gender, cancer site, surgery type, resection type, other organ resection, HIPEC, LN status, tumor invasion, distant metastases, TNM stage, postoperative SAE, systemic chemotherapy and IP chemotherapy. In multivariate analysis, seven factors were identified as independent prognostic factors for long term survival, including resection type, HIPEC, LN status, tumor invasion, distant metastases, postoperative SAE and systemic chemotherapy.
Resection type, HIPEC, postoperative SAE and systemic chemotherapy are four independent prognostic factors that could be intervened for GC patients for improving survival.
胃癌(GC)是中国癌症死亡的第三大主要原因,胃癌患者的预后较差。本研究的目的是探讨接受根治性或姑息性切除、完成临床数据库及随访的胃癌患者的预后因素。
本回顾性研究分析了2004年1月至2010年12月期间来自三家三级转诊教学医院的533例接受根治性或姑息性切除、具有完整临床数据库及随访信息的胃癌患者。采用Kaplan-Meier法确定胃癌特异性总生存(OS)状态,并进行单因素分析以确定可能的生存因素。使用Cox比例风险模型和向前回归程序进行多因素分析,以确定独立的预后因素。
截至最后一次随访,533例胃癌患者的中位随访时间为38.6个月(范围6.9 - 100.9个月),中位胃癌特异性OS为25.3个月(95%CI:23.1 - 27.4个月)。估计的1年、2年、3年和5年胃癌特异性OS率分别为78.4%、61.4%、53.3%和48.4%。单因素分析确定了以下预后因素:医院、年龄、性别、癌症部位、手术类型、切除类型、其他器官切除、腹腔热灌注化疗(HIPEC)、淋巴结状态、肿瘤侵犯、远处转移、TNM分期、术后严重不良事件(SAE)、全身化疗和腹腔内化疗(IP化疗)。多因素分析确定了七个因素为长期生存的独立预后因素,包括切除类型、HIPEC、淋巴结状态、肿瘤侵犯、远处转移、术后SAE和全身化疗。
切除类型、HIPEC、术后SAE和全身化疗是四个可干预的独立预后因素,有助于改善胃癌患者的生存。